Mechanism by which hyperglycemia inhibits hepatic glucose production in conscious rats

Implications for the pathophysiology of fasting hyperglycemia in diabetes

Luciano Rossetti, Andrea Giaccari, Nir Barzilai, Kathleen Howard, Gary Sebel, Meizhu Hu

Research output: Contribution to journalArticle

170 Citations (Scopus)

Abstract

To examine the relationship between the plasma glucose concentration (PG) and the pathways of hepatic glucose production (HGP), five groups of conscious rats were studied after a 6-h fast: (a) control rats (PG = 8.0±0.2 mM); (b) control rats (PG = 7.9±0.2 mM) with somatostatin and insulin replaced at the basal level; (c) control rats (PG = 18.1±0.2 mM) with somatostatin, insulin replaced at the basal level, and glucose infused to acutely raise plasma glucose by 10 mM; (d) control rats (PG = 18.0±0.2 mM) with somatostatin and glucose infusions to acutely reproduce the metabolic conditions of diabetic rats, i.e., hyperglycemia and moderate hypoinsulinemia; (e) diabetic rats (PG = 18.4±2.3 mM). All rats received an infusion of [3-3H]glucose and [U-14C]lactate. The ratio between hepatic [14C]UDP-glucose sp act (SA) and 2X [14C]-phosphoenolpyruvate (PEP) SA (the former reflecting glucose-6-phosphate SA) measured the portion of total glucose output derived from PEP-gluconeogenesis. In control rats, HGP was decreased by 58% in hyperglycemic compared to euglycemic conditions (4.5±0.3 vs. 10.6±0.2 mg/kg·min; P <0.01). When evaluated under identical glycemic conditions, HGP was significantly increased in diabetic rats (18.9±1.4 vs. 6.2±0.4 mg/kg·min; P < 0.01). In control rats, hyperglycemia increased glucose cycling (by 2.5-fold) and the contribution of gluconeogenesis to HGP (91% vs. 45%), while decreasing that of glycogenolysis (9% vs. 55%). Under identical plasma glucose and insulin concentrations, glucose cycling in diabetic rats was decreased (by 21%) and the percent contribution of gluconeogenesis to HGP (73%) was similar to that of controls (84%). These data indicate that: (a) hyperglycemia causes a marked inhibition of HGP mainly through the suppression of glycogenolysis and the increase in glucokinase flux, with no apparent changes in the fluxes through gluconeogenesis and glucose-6-phosphatase; under similar hyperglycemic hypoinsulinemic conditions: (b) HGP is markedly increased in diabetic rats; however, (c) the contribution of glycogenolysis and gluconeogenesis to HGP is similar to control animals.

Original languageEnglish (US)
Pages (from-to)1126-1134
Number of pages9
JournalJournal of Clinical Investigation
Volume92
Issue number3
StatePublished - Sep 1993
Externally publishedYes

Fingerprint

Hyperglycemia
Fasting
Glucose
Liver
Gluconeogenesis
Glycogenolysis
Somatostatin
Phosphoenolpyruvate
Insulin
Uridine Diphosphate Glucose
Glucokinase
Glucose-6-Phosphatase
Glucose-6-Phosphate

Keywords

  • Diabetes mellitus
  • Glucokinase
  • Gluconeogenesis
  • Glucose cycling
  • Glucose-6-phosphatase
  • Glycogenolysis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Mechanism by which hyperglycemia inhibits hepatic glucose production in conscious rats : Implications for the pathophysiology of fasting hyperglycemia in diabetes. / Rossetti, Luciano; Giaccari, Andrea; Barzilai, Nir; Howard, Kathleen; Sebel, Gary; Hu, Meizhu.

In: Journal of Clinical Investigation, Vol. 92, No. 3, 09.1993, p. 1126-1134.

Research output: Contribution to journalArticle

@article{e77593908fce4c498753e9cb7dad996d,
title = "Mechanism by which hyperglycemia inhibits hepatic glucose production in conscious rats: Implications for the pathophysiology of fasting hyperglycemia in diabetes",
abstract = "To examine the relationship between the plasma glucose concentration (PG) and the pathways of hepatic glucose production (HGP), five groups of conscious rats were studied after a 6-h fast: (a) control rats (PG = 8.0±0.2 mM); (b) control rats (PG = 7.9±0.2 mM) with somatostatin and insulin replaced at the basal level; (c) control rats (PG = 18.1±0.2 mM) with somatostatin, insulin replaced at the basal level, and glucose infused to acutely raise plasma glucose by 10 mM; (d) control rats (PG = 18.0±0.2 mM) with somatostatin and glucose infusions to acutely reproduce the metabolic conditions of diabetic rats, i.e., hyperglycemia and moderate hypoinsulinemia; (e) diabetic rats (PG = 18.4±2.3 mM). All rats received an infusion of [3-3H]glucose and [U-14C]lactate. The ratio between hepatic [14C]UDP-glucose sp act (SA) and 2X [14C]-phosphoenolpyruvate (PEP) SA (the former reflecting glucose-6-phosphate SA) measured the portion of total glucose output derived from PEP-gluconeogenesis. In control rats, HGP was decreased by 58{\%} in hyperglycemic compared to euglycemic conditions (4.5±0.3 vs. 10.6±0.2 mg/kg·min; P <0.01). When evaluated under identical glycemic conditions, HGP was significantly increased in diabetic rats (18.9±1.4 vs. 6.2±0.4 mg/kg·min; P < 0.01). In control rats, hyperglycemia increased glucose cycling (by 2.5-fold) and the contribution of gluconeogenesis to HGP (91{\%} vs. 45{\%}), while decreasing that of glycogenolysis (9{\%} vs. 55{\%}). Under identical plasma glucose and insulin concentrations, glucose cycling in diabetic rats was decreased (by 21{\%}) and the percent contribution of gluconeogenesis to HGP (73{\%}) was similar to that of controls (84{\%}). These data indicate that: (a) hyperglycemia causes a marked inhibition of HGP mainly through the suppression of glycogenolysis and the increase in glucokinase flux, with no apparent changes in the fluxes through gluconeogenesis and glucose-6-phosphatase; under similar hyperglycemic hypoinsulinemic conditions: (b) HGP is markedly increased in diabetic rats; however, (c) the contribution of glycogenolysis and gluconeogenesis to HGP is similar to control animals.",
keywords = "Diabetes mellitus, Glucokinase, Gluconeogenesis, Glucose cycling, Glucose-6-phosphatase, Glycogenolysis",
author = "Luciano Rossetti and Andrea Giaccari and Nir Barzilai and Kathleen Howard and Gary Sebel and Meizhu Hu",
year = "1993",
month = "9",
language = "English (US)",
volume = "92",
pages = "1126--1134",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "3",

}

TY - JOUR

T1 - Mechanism by which hyperglycemia inhibits hepatic glucose production in conscious rats

T2 - Implications for the pathophysiology of fasting hyperglycemia in diabetes

AU - Rossetti, Luciano

AU - Giaccari, Andrea

AU - Barzilai, Nir

AU - Howard, Kathleen

AU - Sebel, Gary

AU - Hu, Meizhu

PY - 1993/9

Y1 - 1993/9

N2 - To examine the relationship between the plasma glucose concentration (PG) and the pathways of hepatic glucose production (HGP), five groups of conscious rats were studied after a 6-h fast: (a) control rats (PG = 8.0±0.2 mM); (b) control rats (PG = 7.9±0.2 mM) with somatostatin and insulin replaced at the basal level; (c) control rats (PG = 18.1±0.2 mM) with somatostatin, insulin replaced at the basal level, and glucose infused to acutely raise plasma glucose by 10 mM; (d) control rats (PG = 18.0±0.2 mM) with somatostatin and glucose infusions to acutely reproduce the metabolic conditions of diabetic rats, i.e., hyperglycemia and moderate hypoinsulinemia; (e) diabetic rats (PG = 18.4±2.3 mM). All rats received an infusion of [3-3H]glucose and [U-14C]lactate. The ratio between hepatic [14C]UDP-glucose sp act (SA) and 2X [14C]-phosphoenolpyruvate (PEP) SA (the former reflecting glucose-6-phosphate SA) measured the portion of total glucose output derived from PEP-gluconeogenesis. In control rats, HGP was decreased by 58% in hyperglycemic compared to euglycemic conditions (4.5±0.3 vs. 10.6±0.2 mg/kg·min; P <0.01). When evaluated under identical glycemic conditions, HGP was significantly increased in diabetic rats (18.9±1.4 vs. 6.2±0.4 mg/kg·min; P < 0.01). In control rats, hyperglycemia increased glucose cycling (by 2.5-fold) and the contribution of gluconeogenesis to HGP (91% vs. 45%), while decreasing that of glycogenolysis (9% vs. 55%). Under identical plasma glucose and insulin concentrations, glucose cycling in diabetic rats was decreased (by 21%) and the percent contribution of gluconeogenesis to HGP (73%) was similar to that of controls (84%). These data indicate that: (a) hyperglycemia causes a marked inhibition of HGP mainly through the suppression of glycogenolysis and the increase in glucokinase flux, with no apparent changes in the fluxes through gluconeogenesis and glucose-6-phosphatase; under similar hyperglycemic hypoinsulinemic conditions: (b) HGP is markedly increased in diabetic rats; however, (c) the contribution of glycogenolysis and gluconeogenesis to HGP is similar to control animals.

AB - To examine the relationship between the plasma glucose concentration (PG) and the pathways of hepatic glucose production (HGP), five groups of conscious rats were studied after a 6-h fast: (a) control rats (PG = 8.0±0.2 mM); (b) control rats (PG = 7.9±0.2 mM) with somatostatin and insulin replaced at the basal level; (c) control rats (PG = 18.1±0.2 mM) with somatostatin, insulin replaced at the basal level, and glucose infused to acutely raise plasma glucose by 10 mM; (d) control rats (PG = 18.0±0.2 mM) with somatostatin and glucose infusions to acutely reproduce the metabolic conditions of diabetic rats, i.e., hyperglycemia and moderate hypoinsulinemia; (e) diabetic rats (PG = 18.4±2.3 mM). All rats received an infusion of [3-3H]glucose and [U-14C]lactate. The ratio between hepatic [14C]UDP-glucose sp act (SA) and 2X [14C]-phosphoenolpyruvate (PEP) SA (the former reflecting glucose-6-phosphate SA) measured the portion of total glucose output derived from PEP-gluconeogenesis. In control rats, HGP was decreased by 58% in hyperglycemic compared to euglycemic conditions (4.5±0.3 vs. 10.6±0.2 mg/kg·min; P <0.01). When evaluated under identical glycemic conditions, HGP was significantly increased in diabetic rats (18.9±1.4 vs. 6.2±0.4 mg/kg·min; P < 0.01). In control rats, hyperglycemia increased glucose cycling (by 2.5-fold) and the contribution of gluconeogenesis to HGP (91% vs. 45%), while decreasing that of glycogenolysis (9% vs. 55%). Under identical plasma glucose and insulin concentrations, glucose cycling in diabetic rats was decreased (by 21%) and the percent contribution of gluconeogenesis to HGP (73%) was similar to that of controls (84%). These data indicate that: (a) hyperglycemia causes a marked inhibition of HGP mainly through the suppression of glycogenolysis and the increase in glucokinase flux, with no apparent changes in the fluxes through gluconeogenesis and glucose-6-phosphatase; under similar hyperglycemic hypoinsulinemic conditions: (b) HGP is markedly increased in diabetic rats; however, (c) the contribution of glycogenolysis and gluconeogenesis to HGP is similar to control animals.

KW - Diabetes mellitus

KW - Glucokinase

KW - Gluconeogenesis

KW - Glucose cycling

KW - Glucose-6-phosphatase

KW - Glycogenolysis

UR - http://www.scopus.com/inward/record.url?scp=0027199061&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027199061&partnerID=8YFLogxK

M3 - Article

VL - 92

SP - 1126

EP - 1134

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 3

ER -